WAIVER, CONSENT AND OPTION TERMINATION AGREEMENTWaiver, Consent and Option Termination Agreement • March 8th, 2013 • Cadence Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Waiver, Consent and Option Termination Agreement (the “Agreement”) is made and entered into as of the 11th day of December, 2012 (the “Effective Date”), by and between INCLINE THERAPEUTICS, INC., a Delaware corporation (the “Company”), and CADENCE PHARMACEUTICALS, INC., a Delaware corporation (“Cadence”).
LICENSE AGREEMENTLicense Agreement • March 8th, 2013 • Cadence Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This LICENSE AGREEMENT (“License Agreement”) is made and entered into, as of November 27, 2012, by and between on the one hand, Cadence Pharmaceuticals, Inc., a corporation organized under the laws of the state of Delaware (“Cadence”), and SCR Pharmatop, a civil law partnership organized and existing under the laws of France (“Pharmatop”) (collectively “Cadence Parties”), and on the other hand, Paddock Laboratories, LLC, a limited liability company formed under the laws of the State of Delaware (“Paddock”), and Perrigo Company, a corporation existing under the laws of Michigan (“Perrigo”), (each a “Party”, and, collectively, the “Parties”).
SETTLEMENT AGREEMENTSettlement Agreement • March 8th, 2013 • Cadence Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Pursuant to Rule 41(a)(2) of the FEDERAL RULES OF CIVIL PROCEDURE, the Plaintiffs, Cadence Pharmaceuticals, Inc. and SCR Pharmatop, and Defendants Perrigo Company, Paddock Laboratories, Inc., and Paddock Laboratories, LLC (collectively “the Parties”) hereby stipulate to the entry of the attached proposed Order of Dismissal, dismissing with prejudice all claims, counterclaims, and defenses as between the Parties, with the Parties bearing their own costs.
